GlaxoSmithKline To Pay $3 Billion To Settle Charges

Jul 3, 2012

British drugmaker GlaxoSmithKline has agreed to pay $3 billion to settle charges that it illegally marketed some of its most popular drugs. U.S. officials say among other things, the company promoted an antidepressant to children that was approved only for adults.